Journal article 573 views 50 downloads
Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study
,
Alan Watkins ,
Jane Lyons,
Ashley Akbari ,
Rowena Bailey,
L. Bethell,
A. Carson-Stevens,
A. Edwards,
Helena Emery,
Bridie Evans,
S. Jolles,
Ann John ,
Mark Kingston ,
Alison Porter ,
Berni Sewell ,
Victoria Williams,
Ronan Lyons
Public Health, Volume: 218, Pages: 12 - 20
Swansea University Authors:
Helen Snooks , Alan Watkins , Jane Lyons, Ashley Akbari , Rowena Bailey, Helena Emery, Bridie Evans, Ann John , Mark Kingston , Alison Porter , Berni Sewell , Victoria Williams, Ronan Lyons
-
PDF | Version of Record
Distributed under the terms of a Creative Commons Attribution 4.0 License (CC-BY).
Download (478.42KB)
DOI (Published version): 10.1016/j.puhe.2023.02.008
Abstract
Introduction: The UK shielding policy intended to protect people at highest risk of harm from COVID-19infection. We aimed to describe intervention effects in Wales at 1 year.Methods: Retrospective comparison of linked demographic and clinical data for cohorts comprisingpeople identified for shieldin...
| Published in: | Public Health |
|---|---|
| ISSN: | 0033-3506 |
| Published: |
Elsevier BV
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa62664 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract: |
Introduction: The UK shielding policy intended to protect people at highest risk of harm from COVID-19infection. We aimed to describe intervention effects in Wales at 1 year.Methods: Retrospective comparison of linked demographic and clinical data for cohorts comprisingpeople identified for shielding from 23rd March to 21st May 2020; and the rest of the population.Health records were extracted with event dates between 23rd March 2020 and 22nd March2021 for the comparator cohort and from the date of inclusion until one year later for theshielded cohort.Results: The shielded cohort included 117,415 people, with 3,086,385 in the comparator cohort. Thelargest clinical categories in the shielded cohort were severe respiratory condition (35.5%),immunosuppressive therapy (25.9%) and cancer (18.6%). People in the shielded cohort weremore likely to be female, aged >= 50, living in relatively deprived areas, care home residentsand frail.The proportion of people tested for COVID-19 was higher in the shielded cohort (OR 1.616;95% CI 1.597 -1.637), with lower positivity rate IRR 0.716 (95% CI 0.697 – 0.736). The knowninfection rate was higher in the shielded cohort (5.9% versus 5.7%).People in the shielded cohort were more likely to die (OR 3.683; 95% CI: 3.583 – 3.786); havea critical care admission (OR 3.339; 95% CI: 3.111 – 3.583), hospital emergency admission(OR 2.883; 95% CI: 2.837 – 2.930), Emergency Department attendance (OR 1.893; 95% CI:1.867 – 1.919) and Common Mental Disorder (OR 1.762; 95% CI: 1.735 – 1.789).Conclusion: Deaths and healthcare utilisation were higher amongst shielded people than the generalpopulation, as would be expected in the sicker population. Differences in testing rates,deprivation and pre-existing health are potential confounders, however lack of clear impact oninfection rates raises questions about the success of shielding and indicates that furtherresearch is required to fully evaluate this national policy intervention. |
|---|---|
| Item Description: |
Correction to article found here: https://doi.org/10.1016/j.puhe.2023.06.001 |
| Keywords: |
Covid-19, pandemic |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
National Core Studies Immunity programme (led from
Birmingham University), in turn funded by the Medical Research Council [MR/V028367/1];
Health Data Research UK [HDR-9006] which receives its funding from the UK Medical
Research Council, Engineering and Physical Sciences Research Council, Economic and
Social Research Council, Department of Health and Social Care (England), Chief Scientist
Office of the Scottish Government Health and Social Care Directorates, Health and Social
Care Research and Development Division (Welsh Government), Public Health Agency
(Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust; and
Administrative Data Research UK which is funded by the Economic and Social Research
Council [grant ES/S007393/1]. This work was supported by the Wales COVID-19 Evidence
Centre, funded by Health and Care Research Wales. |
| Start Page: |
12 |
| End Page: |
20 |